Session IV: Dyslipidemia/Atherosclerosis/Thrombosis

CME Symposium

Primetime CME Symposium Current and Emerging Therapeutics in Hyperlipidemia

Speaker(s)

• 

  Pam R. Taub, MD, FACC

  Professor of Medicine
  UC San Diego
  UC San Diego
  La Jolla, California, United States
• 

  Pamela B. Morris, MD, FACC, FAHA, FASPC, FESC, FNLA (she/her/hers)

  Director, Seinsheimer Cardiovascular Health ProgramPaul V Kramer Chair of Cardiovascular Disease Prevention
  The Medical University of South Carolina
  The Medical University of South Carolina
  Mount Pleasant, South Carolina, United States
• 

  Patrick M. Moriarty, MD, FACP, FACC, FNLA, FESC

  Director of Atherosclerosis and Lipoprotein-apheresis Center Pharmacology
  The University of Kansas Health System
  Kansas University Medical Center
  Kansas City, Kansas, United States